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Abstract
Case-control studies on adults point to an increased risk of brain tumours (glioma and acoustic neuroma)
associated with the long-term use of mobile phones. Recently, the first study on mobile phone use and the risk of
brain tumours in children and adolescents, CEFALO, was published. It has been claimed that this relatively small
study yielded reassuring results of no increased risk. We do not agree. We consider that the data contain several
indications of increased risk, despite low exposure, short latency period, and limitations in the study design,
analyses and interpretation. The information certainly cannot be used as reassuring evidence against an association,
for reasons that we discuss in this commentary.
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Background
There has been a rapid increase in the use of mobile
phones in recent years. Today about 5 billion people
worldwide are estimated to be users, many of whom are
children and teenagers. Other wireless phones, e.g. cordless
phones of the Digital Enhanced Cordless Telecommunica-
tion (DECT) type, are also common and can be as fre-
quently used, if not more so. Both give a relatively high
exposure to radiofrequency electromagnetic fields (RF-
EMF) [1], an environmental exposure that the International
Agency for Research on Cancer (IARC) has recently classi-
fied as ‘possibly carcinogenic to humans’, Group 2B [2].
Meta-analyses have shown an increased risk of malig-
nant brain tumours and acoustic neuroma associated with
long-term (> 10 years) use of mobile phone, and particu-
larly where laterality has been considered, i.e., a tumour
has developed on the same side of the head as the phone
was generally used [3-6]. The Hardell group also analysed
the risk in different age categories for first use of mobile
or cordless phones [3,7]. First use before the age of 20
yielded the highest risk, as did use in the youngest age
group at diagnosis [8]. This higher risk associated with use
at a young age may reflect potentially higher susceptibility
to RF-EMF among children and adolescents [9]. The near
f i e l de x p o s u r et oR F - E M Ff r o mah a n d s e tt ot h eb r a i n
means that the absorbed energy may be higher for young
persons than adults [10] due to their thinner bones, smal-
ler heads and higher conductivity of their brains. The
developing brain is also more sensitive than an adult brain
to toxins [9]. Despite these considerations data on children
are scarce.
T h ef i r s ts t u d yo nm o b i l ep h o n eu s ea n dt h er i s ko f
brain tumours in children and adolescents, CEFALO, has
recently been published [11]. In this commentary, we will
discuss its design, findings and, importantly, the authors’
conclusions since this issue is highly relevant to public
health [A].
CEFALO
The multi-centre case-control study, CEFALO, conducted
in Denmark, Sweden, Norway, and Switzerland, included
children and adolescents aged 7-19 years diagnosed with a
brain tumour between 2004 and 2008 [11]. The results
were based on interviews with 352 cases (83.2% partici-
pated) and 646 controls (71.1% participated) and their par-
ents. Controls were selected randomly, mostly from
population registries [B], and matched by age, sex and geo-
graphical region. The study period was from January 1,
2004 until August 31, 2008, but varied “slightly between
study centres”. Conditional logistic regression models
were used for statistical analysis. The reference category in
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corresponding 95% confidence intervals (CI) consisted of
subjects who were either non-users or non-regular users
of mobile phones. The latter were those who reported < 1
call per week for at least 6 months.
In the summary the authors state that they “did not
observe that regular use of a mobile phone increased the
risk of brain tumors”. This conclusion was accompanied
by an editorial stating that the study showed “no increased
risk of brain tumors” [12], and a news release from the
Karolinska Institute in Stockholm that the results were
“reassuring” of no increased risk [13]. We do not agree
with these conclusions, and will address different issues in
the study to explain why this is the case.
Discussion
Risk related to mobile phone use
Regular use of mobile phones was reported by 55% (n =
194) of the cases and 51% (n = 329) of the controls. The
study yielded a statistically non-significant, but increased
risk for brain tumours among regular users of mobile
phones (OR 1.36; 95% CI 0.92 to 2.02). However, if the
study had been implemented as designed [14], with 550
cases and 2 controls per case, it would have been able to
detect a 35% increased risk with 80% power. In other
words, if the investigators had had 550 cases in the study
and the overall result was similar, the 36% increased risk
in brain tumours reported for ‘regular’ mobile phone users
could have been statistically significant. With 352 cases,
the study could only detect a 45% increased risk as statisti-
cally significant with the same (80%) power.
Nevertheless, in the absence of a statistically significant
trend, the OR in question increased with cumulative dura-
tion of subscriptions and duration of calls. At most only a
latency time of > 5 years reported by 46 cases and 81 con-
trols was presented, with no data on longer-term use. In
fact, the numbers of cases and controls is unclear, since
the report states that for a latency time of 5 years, 33 cases
and 45 controls were exposed-numbers that are not com-
patible with those for > 5 years.
The authors also present results of stratified analyses
that yielded ORs ranging from 1.49 to 1.73 for Denmark,
Sweden and Switzerland. In contrast, Norway’sO Rw a s
0.51, although “...in line with random variability (P for het-
erogeneity = 0.20)” as noted by the authors without further
discussion. If the ORs 1.73, 1.49, 1.69 and 0.51 are found
by the test to be ‘homogeneous’, then the power of the test
should be questioned. The latter and the clearly lower
response rate for Norway than for the other 3 countries
give reason to worry that this may indicate some impor-
tant methodological difference or bias.
Further support of a true association was found in the
results based on operator-recorded use for 62 cases and
101 controls, which for time since first subscription
> 2.8 years yielded OR 2.15 (95% CI 1.07-4.29) with a
statistically significant trend (P = 0.001). The results
based on such records would be judged to be more
objective than face-to-face interviews, as in the study,
that clearly disclosed to the interviewer who was a case
or a control. The authors disregarded these results on
the grounds that there was no significant trend for
operator data for the other variables – cumulative dura-
tion of subscriptions, cumulative duration of calls and
cumulative number of calls. However, the statistical
power in all the latter groups was lower since data was
missing for about half of the cases and controls with
operator-recorded use, which could very well explain
the difference in the results.
Risk related to localisation, tumour morphology and
laterality
An increased risk was found for localisations of brain
tumours other than the most exposed, e.g. temporal lobe,
frontal lobe and cerebellum, which of course present a
problem for drawing causal conclusions. Indeed, this was
one of the authors’ 2 main arguments as to why they
thought the relationship was not causal. Instead, the
authors argue that prodromal symptoms before diagnosis
may have prompted the use of mobile phones and thereby
possibly introduced reverse causality. However, this expla-
nation seems unfounded for 2 reasons. First, to our knowl-
edge there are no studies where this hypothesis gains
empirical support. Second, the severity and duration of
prodromal symptoms are highly dependent on type of
brain tumour; hence, such symptoms are unlikely to have
occurred for long enough for the vast majority of the dura-
tion of exposure in most patients to explain the increased
risk.
It should also be pointed out that childhood tumours
differ from those on adults regarding their anatomical dis-
tribution and histopathology [15]. Moreover, one study on
adults that presented results specifically for different types
of glioma, e.g., low-grade and high-grade astrocytoma [16],
indicated different risk patterns depending on the severity
of the disease, with the highest risk being for high-grade
astrocytoma. Most astrocytomas in children are of the
low-grade type, relatively few being high-grade [15]. In
conjunction with the poor prognosis of high-grade astro-
cytoma (5-year survival of 28% vs. 93% for low-grade), this
would indicate that most of the astrocytomas in CEFALO
were of the low-grade type. Thus, although the study was
relatively small, further subgroup analyses for “astrocy-
toma and other glioma” would have been of interest (and
perhaps other specific tumourt y p e s ,e . g .e p e n d y m o m a
and medulloblastoma).
Most calculations of laterality show a trend of increasing
risk for time since first use, cumulative duration of sub-
scriptions, cumulative duration of calls, and cumulative
Söderqvist et al. Environmental Health 2011, 10:106
http://www.ehjournal.net/content/10/1/106
Page 2 of 5number of calls (Table five) [11]. However, this trend was
seen not only for ipsilateral use, but also for contralateral
use. One explanation might be that the preponderance for
any particular side in childhood might be less valid than
for adults. They use mobile phones in different ways than
adults, and might shift the ear depending on their current
activity. To disregard the findings without a more thor-
ough analysis is, in this context, not appropriate.
F u r t h e r m o r e ,t h er e s u l t si nT a b l ef i v e[ 1 1 ]w e r eb a s e d
on 179 exposed cases versus 194 in total, and 281 exposed
controls versus 329 in total. No explanation was given
why data was missing for 15 cases and 48 controls com-
pared to the overall analyses. The numbers of “no regular
use” for cases and controls also varies in the different cal-
culations. As for the results one might suspect some sort
of systematic error, judging by the decreasing trends in
risk seen for the category ‘central or unknown location’,
which naturally also casts doubt on the results of the other
2 categories, ‘ipsi- and contralateral use’, that showed
opposite trends, i.e., ORs that increased by exposure. It is
difficult to see why the authors chose to combine the cen-
trally located tumours with those of unknown origin.
Together these 2 form a larger group of exposed cases
(n = 68) than the other 2 (ipsilateral n = 62, contralateral
n = 49). With no information on the size of the ‘unknown
location’ group, one cannot form an opinion on whether it
is likely to have influenced the results in the categories for
ipsi- and contra-lateral use.
Risk related to cordless phone use
The manner in which the data on cordless phone use were
collected and analysed raises additional validity concerns.
First, the study should have considered wireless phone use
to include both mobile and cordless phones as the expo-
sure category. IARC adopted the term “wireless phone
use” as the relevant exposure group [2]. Second, the unex-
posed group should consist of subjects with no use of
wireless phones. Instead, Aydin et al. [11] included use of
cordless phones in the ‘unexposed’ category and thus the
risk estimates for mobile phone use might be diluted
towards unity. Similarly, mobile phone use was included
among the ‘unexposed’ group when considering use of
cordless phones, thereby potentially concealing an
increased risk.
For cordless phones, no information on regular use was
given, only ‘ever use’, which was reported by 68.8% (n =
242) of the cases and 66.6% (n = 430) of the controls.
Furthermore, use of cordless phones was assessed only ‘in
the first 3 years’ of use, a most peculiar definition for
which the authors give neither explanation nor reference.
Is there any good evidence to claim that individual differ-
ences in use among participants the first 3 years are repre-
sentative of the following years? If not, this would give rise
to exposure misclassification; but even if it was
representative, it would not give the complete information
regarding cumulative hours of use. In fact, the use of cord-
less phones increases rapidly over time in childhood; teen-
agers talk substantially more on cordless phones than
children. Thus, excluding use later than the first 3 years
probably precludes assessment of a relatively large
exposure.
Further, data was provided neither on laterality nor on
time since first use. Does the latter mean that all partici-
pants had used a cordless phone with a latency time of
3y e a r s ?O u rs t u d i e so nu s eo fw i r e l e s sp h o n e sa m o n g
Swedish children and teenagers (aged 7-19 years con-
ducted during 2005-2006) indicated that the cordless
phone was more frequently used for talking than the
mobile phone in all age groups [17,18]. In total, 82.9%
of the subjects aged 7-19 years reported access to a
cordless phone. Of those, 52% talked on average > 5
minutes per day, which was the second lowest exposure
category in our study. Talking 5 minutes per day for, e.
g., 3 years amounts to ~91 cumulative hours of use,
which corresponds to the highest exposure category in
CEFALO, > 70 hours. This is equivalent to an average
of 3.8 minutes or more per day for 3 years, i.e. in our
opinion, not necessarily a highly exposed group. There-
fore, it would have been useful to have information
regarding the distribution of exposure within that cate-
gory (n = 25 cases; 38 controls).
Furthermore, numbers in Table six of Aydin et al. [11]
are inconsistent. No use of cordless phones overall was
reported by 110 cases and 216 controls, but, 102 cases
and 189 controls are stated to be unexposed in the calcu-
lations of cumulative duration and number of calls. Data
are also missing for 116 cases and 224 controls in calcu-
lations of the cumulative duration of calls and similar
numbers for cumulative number of calls, i.e. ~50% of the
cases and the controls reporting “ever use of cordless
phones”. The authors were careful to note missing cases
and controls where mobile phone results were shown
(see footnote, Table two) [11], but had no comment why
such a large percentage of the data were missing on cord-
less phones. For both cumulative hours and for cumula-
tive calls the risk seems to increase monotonically with
increasing exposure; hence, one wonders what the p-
trend value (0.20) in Table six [11] would be had the
missing cases been included.
Finally, the authors conclude that no increased brain
tumour risk was associated with use of cordless phones in
CEFALO and claim that the results contradict estimates of
brain tumour risk in our studies that we reported to be of
the same order of magnitude for both mobile and cordless
phones [16]. Use differs greatly between the studies, which
could explain the discrepancy. The highest exposure cate-
gory for cumulative hours of use in our report was > 2000
hours, while in CEFALO it was > 70 hours.
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The authors compare their results with ours for first use of
wireless phone before 20 years of age [3,7]. They neglect
the fact that we used wireless phone use as the exposure
group (divided into mobile and cordless phones, with no
such use as the unexposed category), studied subjects aged
20-80 years, and other tumour types (astrocytoma grade
I-IV). Furthermore, the medium latency period for sub-
jects with first use before 20 years of age was 6 years for
mobile phone and 7 years for cordless phone, which differs
from the much shorter latency period in CEFALO. Their
editorial neglected these obvious facts [12].
Incidence
The authors present incidence data from the Swedish
Cancer Registry between 1990-2008 for the age group
5-19 years including hypothetical incidence rate trends,
concluding that there was no increase in incidence. Calcu-
lations were made on how much the incidence would
have increased in the last 10 years (~50%), given a relative
risk (OR) of 2.15 after 3 years of regular use of mobile
phone (cordless phone use being disregarded). To make
the above calculation, information was needed on the pro-
portion of regular use in the source population during
these years. That was estimated by combining data from
the control subjects in CEFALO with subscriber data in
Sweden. First, this calculation implies that ‘regular use’
(meaning one phone call a week for at least 6 months) is a
relevant exposure metric for studying a possible carcino-
genic effect of RF-EMF, with which we do not agree (see
below). Second, it is not clear how data, as defined in the
study, was combined from the controls in CEFALO with
subscriber data in Sweden to retrieve the proportion of
regular users. Furthermore, we wonder why only data for
Sweden was analysed in the time trend analysis. The inci-
dence of brain and central nervous system tumours may
not be comparable between Nordic countries because of e.
g. different rules regarding the inclusion of benign or
unspecified tumours. Based on data in NORDCAN [19],
we found in the age group 5-19 years a annual statistically
significant increase in incidence of 3.3% (95% CI 0.8 to
5.9) in males and 2.5% (95% CI 0.2 to 4.9) in females for
the period 1990-2008 in Norway, a result quite different
from Denmark and Sweden (Table 1). Thus, one needs to
be cautious using incidence data to dismiss results in ana-
lytical epidemiology. It should be noted that the quality of
the Swedish Cancer Registry in reporting of CNS tumours,
particularly high grade glioma, has been seriously ques-
tioned [20,21].
Conclusions
Further studies are required on the risk of brain tumours
in children associated with use of mobile and cordless
phones; future investigations must meet basic demands on
quality, by which we mean not only efforts undertaken to
assure reliable assessment of exposure and outcome, but
also to obtain a sufficient number of cases and controls of
which not just a few by modern measures have been
exposed. The biological mechanism by which RF-EMF
exposure might cause or promote cancer remains
unknown. Since we lack that knowledge, any assumption
made about exposure-response relations and the threshold
of any increased risk is premature. In view of the latter
and the limited statistical power in CEFALO the main
conclusion of Aydin et al. of lack of an exposure-response
relationship argues against a causal association seems
unwarranted.
Our own research shows that some teenagers, particu-
larly girls, report spending several hours on average per
day using a cordless phone. If that information is correct,
their amount of cumulative use may exceed 70 hours in a
month, not years like that reported in CEFALO. The study
was relatively small and scarcely gives any information on
the risk for heavy and long-term use, and certainly is not
Table 1 Estimated change in incidence rate/year (%) and 95% confidence interval (CI) for brain and central nervous
system tumours in the age group 5-19 years in Nordic countries 1990-2008 according to NORDCAN
Men Women
Change in incidence rate/year (%) 95% CI n Change in incidence rate/year (%) 95% CI n
Nordic countries*
1990-2008 -0.1 -1.2, 1.1 1 779 +0.8 -0.3, 2.0 1 541
Denmark
1990-2008 -1.1 -3.5, 1.3 418 +0.5 -1.9, 3.1 347
Norway
1990-2008 +3.3 0.8, 5.9 347 +2.5 0.2, 4.9 314
Sweden
1990-2008 -2.3 -3.5, -1.1 631 +0.3 -1.6, 2.2 546
Calculations were based on incidence rates age adjusted to the world standard population and rounded to two decimal places. Linear regression analysis on the
logarithm of the age-adjusted incidence rates was used to calculate the trends.
* = Denmark, Finland, Iceland, Norway, Sweden.
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increased risk of glioma has consistently been shown for
longer latency times, e.g. > 7 [22] and 10 years [3-7]. Yet,
in spite of low exposure, short latency period and limita-
tions in study design, analyses and interpretation, there are
nevertheless indications of increased risk in CEFALO. In
any case, it is to go far beyond the findings of the study to
say that the results are reassuring of no significant
increased risk.
Finally, carcinogenesis is a multistage event and the
cancer incidence depends on initiation, promotion and
progression of the disease [23]. It follows that, since the
mechanism for a possible carcinogenic effect of RF-EMF
exposure is unknown, descriptive incidence data are of
limited value and should currently be of secondary
importance to those based on analytical epidemiology.
Endnotes
A. A letter was submitted to JNCI soon after Aydin et
al. published their results. Two months later we had
received no decision (or reply) in the matter why we
decided to withdraw the letter and instead write this
commentary.
B. Due to the lack of a national population registry in
Switzerland a two-stage sampling procedure was applied:
first, by randomly determining a community within the
same language region as the patient, and second, by ran-
domly selecting a control subject from the correspond-
ing communal population registry.
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